Loading company…
TOMOCLOUD develops non-invasive bioimaging devices for health monitoring.
TOMOCLOUD develops bioimaging devices, including the LT Monitor Lite, which uses electrical impedance tomography to monitor swelling at home. The device is intended to support patients, caregivers, and healthcare providers in monitoring conditions such as lymphedema. Founded in 2025 and based in Chiba-shi, Japan, the company raised JPY 50 million in Seed funding from UntroD Capital on December 26, 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in